Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Slides: 1–3 of 3
Add to tray Remove from tray

Clinically Significant Outcomes of Interest in the Comparative Effectiveness Review

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | disease activity | ACR | radiographic evidence of progression | functional capacity | HAQ | quality of life | SF-36 | DAS
Add to tray Remove from tray

Analytic Methods Used in the Systematic Review

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | ACR20 | disease activity | functional ability | HAQ | Health Assessment Questionnaire | health-related quality of life | SF-36 | Sharp/van de Heijde | joint damage
Add to tray Remove from tray

Summary of Results: Head-to-Head Comparisons of Biologic DMARDs

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: abatacept | adalimumab | anti-rheumatic | antirheumatic | biologic DMARD | disease activity | disease-modifying | DMARDs | early RA | etanercept | functional capacity | infliximab | nonbiologic DMARD | oral DMARD | RA | radiographic progression | rheumatic | symptom response | rheumatoid arthritis
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364